Profounda, Inc. Launches Second Product this Year, Rhinase®, the Only Non-Prescription, Wetting-Agent Based Nasal Moisturizer that will Help People with Nasal Dryness
Orlando, FL (PRWEB) July 19, 2016 -- Profounda, Inc. ("Profounda") announced today that Rhinase® is now available in the United States immediately on Rhinase.com and Amazon.
Today, patients have limited options for controlling problematic nasal symptoms. Saline rinses use mechanical force to clear clogged noses but are not focused on moisturizing, while steroids may be needed to control symptoms of moderate-to-severe allergic rhinitis, yet overuse can be an issue. A 2010 nasal allergy survey revealed that nearly 64 percent of patients discontinue the use of nasal steroid prescriptions due to the unwanted side effects. Both saline rinses and steroids along with other decongestants may leave your nasal passages overly dry resulting in burning and stinging. This can leads to excess mucus created by your body as it tries to compensate for the lack of moisture. Only Rhinase is formulated with two salts and two wetting agents designed to work alone or with your other allergy products to provide the extra moisture needed for a dry nose.
"Wetting agents have been proven to help patients with nasal dryness since the 1980’s " said Todd MacLaughlan, CEO of Profounda, “Rhinase will also complement the use of steroids because unlike many products, it has the same pH and therefore is less likely to interfere with the steroids effectiveness.”
Todd MacLaughlan, Profounda, Inc., http://www.profounda.com, +1 (407) 270-7790, [email protected]
Share this article